Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control trypanosoma cruzi infection

Yasushi Miyahira, Yasuhiro Takashima, Seiki Kobayashi, Yasunobu Matsumoto, Tsutomu Takeuchi, Mutsuko Ohyanagi-Hara, Ayako Yoshida, Akihiko Ohwada, Hisaya Akiba, Hideo Yagita, Ko Okumura, Hideoki Ogawa

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

In order to develop CD8+-T-cell-mediated immunotherapy against intracellular infectious agents, vaccination using recombinant virus vectors has become a promising strategy. In this study, we generated recombinant adenoviral and vaccinia virus vectors expressing a single CD8+-T-celI epitope, ANYNFTLV, which is derived from a Trypanosoma cruzi antigen. Immunogenicity of these two recombinant virus vectors was confirmed by the detection of ANYNFTLV-specific CD8+ T cells in the spleens of immunized mice. Priming/boosting immunization using combinations of these two recombinant virus vectors revealed that the adenovirus vector was efficient for priming and the vaccinia virus vector was effective for boosting the CD8+-T-cell responses. Moreover, we also demonstrated that the ANYNFTLV-specific CD8 +-T-CeIl responses were further augmented by coadministration of recombinant vaccinia virus vector expressing the receptor activator of NFΚB (RANK) ligand as an adjuvant. By priming with the adenovirus vector expressing ANYNFTLV and boosting with the vaccinia virus vectors expressing ANYNFTLV and RANK ligand, the immunized mice were efficiently protected from subsequent challenge with lethal doses of T. cruzi. These results indicated, for the first time, that the induction of immune responses against a single CD8+-T-cell epitope derived from an intrinsic T. cruzi antigen was sufficient to control lethal T. cruzi infection.

Original languageEnglish
Pages (from-to)7356-7365
Number of pages10
JournalInfection and Immunity
Volume73
Issue number11
DOIs
Publication statusPublished - 2005 Nov

Fingerprint

T-Lymphocyte Epitopes
Vaccinia virus
Trypanosoma cruzi
Vaccination
RANK Ligand
Viruses
Infection
T-Lymphocytes
Adenoviridae
Viral Tumor Antigens
Immunotherapy
Epitopes
Immunization
Spleen
Antigens

ASJC Scopus subject areas

  • Immunology

Cite this

Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control trypanosoma cruzi infection. / Miyahira, Yasushi; Takashima, Yasuhiro; Kobayashi, Seiki; Matsumoto, Yasunobu; Takeuchi, Tsutomu; Ohyanagi-Hara, Mutsuko; Yoshida, Ayako; Ohwada, Akihiko; Akiba, Hisaya; Yagita, Hideo; Okumura, Ko; Ogawa, Hideoki.

In: Infection and Immunity, Vol. 73, No. 11, 11.2005, p. 7356-7365.

Research output: Contribution to journalArticle

Miyahira, Y, Takashima, Y, Kobayashi, S, Matsumoto, Y, Takeuchi, T, Ohyanagi-Hara, M, Yoshida, A, Ohwada, A, Akiba, H, Yagita, H, Okumura, K & Ogawa, H 2005, 'Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control trypanosoma cruzi infection', Infection and Immunity, vol. 73, no. 11, pp. 7356-7365. https://doi.org/10.1128/IAI.73.11.7356-7365.2005
Miyahira, Yasushi ; Takashima, Yasuhiro ; Kobayashi, Seiki ; Matsumoto, Yasunobu ; Takeuchi, Tsutomu ; Ohyanagi-Hara, Mutsuko ; Yoshida, Ayako ; Ohwada, Akihiko ; Akiba, Hisaya ; Yagita, Hideo ; Okumura, Ko ; Ogawa, Hideoki. / Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control trypanosoma cruzi infection. In: Infection and Immunity. 2005 ; Vol. 73, No. 11. pp. 7356-7365.
@article{3f6ae1e517be4bf1b54ab3e033c25708,
title = "Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control trypanosoma cruzi infection",
abstract = "In order to develop CD8+-T-cell-mediated immunotherapy against intracellular infectious agents, vaccination using recombinant virus vectors has become a promising strategy. In this study, we generated recombinant adenoviral and vaccinia virus vectors expressing a single CD8+-T-celI epitope, ANYNFTLV, which is derived from a Trypanosoma cruzi antigen. Immunogenicity of these two recombinant virus vectors was confirmed by the detection of ANYNFTLV-specific CD8+ T cells in the spleens of immunized mice. Priming/boosting immunization using combinations of these two recombinant virus vectors revealed that the adenovirus vector was efficient for priming and the vaccinia virus vector was effective for boosting the CD8+-T-cell responses. Moreover, we also demonstrated that the ANYNFTLV-specific CD8 +-T-CeIl responses were further augmented by coadministration of recombinant vaccinia virus vector expressing the receptor activator of NFΚB (RANK) ligand as an adjuvant. By priming with the adenovirus vector expressing ANYNFTLV and boosting with the vaccinia virus vectors expressing ANYNFTLV and RANK ligand, the immunized mice were efficiently protected from subsequent challenge with lethal doses of T. cruzi. These results indicated, for the first time, that the induction of immune responses against a single CD8+-T-cell epitope derived from an intrinsic T. cruzi antigen was sufficient to control lethal T. cruzi infection.",
author = "Yasushi Miyahira and Yasuhiro Takashima and Seiki Kobayashi and Yasunobu Matsumoto and Tsutomu Takeuchi and Mutsuko Ohyanagi-Hara and Ayako Yoshida and Akihiko Ohwada and Hisaya Akiba and Hideo Yagita and Ko Okumura and Hideoki Ogawa",
year = "2005",
month = "11",
doi = "10.1128/IAI.73.11.7356-7365.2005",
language = "English",
volume = "73",
pages = "7356--7365",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control trypanosoma cruzi infection

AU - Miyahira, Yasushi

AU - Takashima, Yasuhiro

AU - Kobayashi, Seiki

AU - Matsumoto, Yasunobu

AU - Takeuchi, Tsutomu

AU - Ohyanagi-Hara, Mutsuko

AU - Yoshida, Ayako

AU - Ohwada, Akihiko

AU - Akiba, Hisaya

AU - Yagita, Hideo

AU - Okumura, Ko

AU - Ogawa, Hideoki

PY - 2005/11

Y1 - 2005/11

N2 - In order to develop CD8+-T-cell-mediated immunotherapy against intracellular infectious agents, vaccination using recombinant virus vectors has become a promising strategy. In this study, we generated recombinant adenoviral and vaccinia virus vectors expressing a single CD8+-T-celI epitope, ANYNFTLV, which is derived from a Trypanosoma cruzi antigen. Immunogenicity of these two recombinant virus vectors was confirmed by the detection of ANYNFTLV-specific CD8+ T cells in the spleens of immunized mice. Priming/boosting immunization using combinations of these two recombinant virus vectors revealed that the adenovirus vector was efficient for priming and the vaccinia virus vector was effective for boosting the CD8+-T-cell responses. Moreover, we also demonstrated that the ANYNFTLV-specific CD8 +-T-CeIl responses were further augmented by coadministration of recombinant vaccinia virus vector expressing the receptor activator of NFΚB (RANK) ligand as an adjuvant. By priming with the adenovirus vector expressing ANYNFTLV and boosting with the vaccinia virus vectors expressing ANYNFTLV and RANK ligand, the immunized mice were efficiently protected from subsequent challenge with lethal doses of T. cruzi. These results indicated, for the first time, that the induction of immune responses against a single CD8+-T-cell epitope derived from an intrinsic T. cruzi antigen was sufficient to control lethal T. cruzi infection.

AB - In order to develop CD8+-T-cell-mediated immunotherapy against intracellular infectious agents, vaccination using recombinant virus vectors has become a promising strategy. In this study, we generated recombinant adenoviral and vaccinia virus vectors expressing a single CD8+-T-celI epitope, ANYNFTLV, which is derived from a Trypanosoma cruzi antigen. Immunogenicity of these two recombinant virus vectors was confirmed by the detection of ANYNFTLV-specific CD8+ T cells in the spleens of immunized mice. Priming/boosting immunization using combinations of these two recombinant virus vectors revealed that the adenovirus vector was efficient for priming and the vaccinia virus vector was effective for boosting the CD8+-T-cell responses. Moreover, we also demonstrated that the ANYNFTLV-specific CD8 +-T-CeIl responses were further augmented by coadministration of recombinant vaccinia virus vector expressing the receptor activator of NFΚB (RANK) ligand as an adjuvant. By priming with the adenovirus vector expressing ANYNFTLV and boosting with the vaccinia virus vectors expressing ANYNFTLV and RANK ligand, the immunized mice were efficiently protected from subsequent challenge with lethal doses of T. cruzi. These results indicated, for the first time, that the induction of immune responses against a single CD8+-T-cell epitope derived from an intrinsic T. cruzi antigen was sufficient to control lethal T. cruzi infection.

UR - http://www.scopus.com/inward/record.url?scp=27744475762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744475762&partnerID=8YFLogxK

U2 - 10.1128/IAI.73.11.7356-7365.2005

DO - 10.1128/IAI.73.11.7356-7365.2005

M3 - Article

C2 - 16239534

AN - SCOPUS:27744475762

VL - 73

SP - 7356

EP - 7365

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 11

ER -